PPT-Update on Prevention of COPD Exacerbations

Introduction Susceptibility to Exacerbation in COPD Lung Function Impairment COPD Hospitalizations and Mortality LongTerm Natural History of COPD Bronchoscopic Validation of the Significance of Sputum Purulence in Severe Exacerbations of COPD. Christopher Worsnop. Department of Respiratory and Sleep . Medicine. Austin Hospital. Melbourne, Australia. COPD DEFINITION. Progressive . airflow . obstruction . that is not fully reversible. .. Most COPD is due to cigarette smoking. COPD is characterized by :. **Chronic airflow obstruction & accelerated . . loss of lung function which is progressive & . NOT. fully reversible.. ** COPD is preventable & treatable but . د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. Key points. An exacerbation of chronic obstructive pulmonary disease is defined as an acute deterioration of respiratory symptoms that needs medical attention and may need a change in regular treatment. Lauren Clark . Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. Oakington. , Cambridge, CB24 3BA. Practice Overview. COPD Patient: COPD QOF diagnosis code. Page 1. Contents. . Patient Demographics. COPD Diagnosis. COPD Health Status. Risk and Exacerbations. Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. : . Asthma, bronchitis, COPD, emphysema, cystic fibrosis, bronchiectasis, pneumoconiosis, sleep apnea. Director ISU Family Medicine Residency. Definition. Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases.. Clinical Trial Evidence. Introduction . Therapeutic Recommendations . Therapeutic Recommendations in Groups B and D . Bronchodilators in Stable COPD. ICS in Stable COPD. COPD . Potential AEs of ICS Treatment. D94- COPD: EPIDEMIOLOGY AND THERAPY. Mini Symposium. Wednesday May 22. Marjan. Kerkhof. 1. , Jaco Voorham. 1. , Claudia Cabrera. 2. , Patrick Darken. 2. , Paul Dorinsky. 2. , . Janwillem. W.H. Kocks. West Suffolk Integrated Formulary . Dr Linda Pearce. Respiratory Consultant Nurse. West Suffolk Hospital NHS Foundation Trust. Declaration . Linda Pearce has undertaken advisory board meetings, lectures and received support to attend educational meetings from. 80 predicted and sometimes but not always Stage II Moderate COPD Worsening airflow limitation FEVbreath typically developing during exertion This is the stage at which patients typically seek medical Faculty MD The Columbia 75 Approach to COPD ExacerbationsCore KnowledgeHallmarks Dyspnea and either increased sputum production or purulenceDifferential Diagnosis expandCHF PE PNARisk FactorsMore fre What is COPD?. How to treat COPD?. What is the prognosis?. 19.3% of US Adults Smoke – 2010. CDC, NHIS 2010. 2010 Current Smokers. %. of Smokers. Demographic. % of Smokers. Demographic. 19.3%. US Adults. disease . is characterized by . . airflow limitation that is not fully . reversible.. The . airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases. .